Clinical Trial

Cohort of Patients With Chronic Myelomonocytic Leukemia

Study acronym: MYELOMONO-3
Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, non-interventional study involving the collection of biological samples with associated anonymised data. Biological samples will be collected at the time of diagnosis and/or as the disease progresses, with or without treatment, always in conjunction with tests scheduled as part of routine care or within the context of a clinical trial.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-02.
Trial Details
NCT Number NCT07512882
Lead Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Conditions Leukemia, Myelomonocytic Leukemia, Chronic
Enrollment 5,000 participants
Start Date 2026-05-05
Primary Completion 2040-03 (estimated)
Study Completion 2040-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-19